Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Horowitz

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Trials|September 28, 2023
RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practiceKatharine A Wallis, Maria Donald, Mark Horowitz, et al.
Psychiatric Rehabilitation Journal|July 25, 2024
An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosisKelly Allott, Allie Pert, Audrey Rattray, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 15, 2021
Methodology for altering omega-3 EPA+DHA and omega-6 linoleic acid as controlled variables in a dietary trialBeth A MacIntosh, Christopher E Ramsden, Gilson Honvoh, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|November 13, 2023
Dietary fatty acids improve perceived sleep quality, stress, and health in migraine: a secondary analysis of a randomized controlled trialKeturah R Faurot, Jinyoung Park, Vanessa Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesisChristoph Anacker, Annamaria Cattaneo, Ksenia Musaelyan, et al.
BMJ Evidence-Based Medicine|April 21, 2025
Challenges in the selection and measurement of outcomes in psychiatric trialsSophie Juul, Pascal Faltermeier, Faiza Siddiqui, et al.
The Lancet Regional Health. Europe|July 26, 2024
Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialitiesSophie Juul, Faiza Siddiqui, Pascal Faltermeier, et al.
Journal of Pediatric Urology|June 14, 2024
Size matters: Total testicular volume predicts sperm count in Tanner V varicocele patientsAlexander H Fang, Israel Franco, Joseph M Pizzuti, et al.
BMJ Open|November 5, 2024
Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnershipMiriam Boland, Agnes Higgins, Claire Beecher, et al.
BMJ Open|June 9, 2025
Protocol for the development of a transdiagnostic core outcome set for mental health disorders in adults: the Patient Important Outcomes in Psychiatry (PIO-Psych) InitiativeSophie Juul, Pascal Faltermeier, Johanne Juul Petersen, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Trials|September 28, 2023
RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practiceKatharine A Wallis, Maria Donald, Mark Horowitz, et al.
Psychiatric Rehabilitation Journal|July 25, 2024
An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosisKelly Allott, Allie Pert, Audrey Rattray, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 15, 2021
Methodology for altering omega-3 EPA+DHA and omega-6 linoleic acid as controlled variables in a dietary trialBeth A MacIntosh, Christopher E Ramsden, Gilson Honvoh, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|November 13, 2023
Dietary fatty acids improve perceived sleep quality, stress, and health in migraine: a secondary analysis of a randomized controlled trialKeturah R Faurot, Jinyoung Park, Vanessa Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2013
Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesisChristoph Anacker, Annamaria Cattaneo, Ksenia Musaelyan, et al.
BMJ Evidence-Based Medicine|April 21, 2025
Challenges in the selection and measurement of outcomes in psychiatric trialsSophie Juul, Pascal Faltermeier, Faiza Siddiqui, et al.
The Lancet Regional Health. Europe|July 26, 2024
Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialitiesSophie Juul, Faiza Siddiqui, Pascal Faltermeier, et al.
Journal of Pediatric Urology|June 14, 2024
Size matters: Total testicular volume predicts sperm count in Tanner V varicocele patientsAlexander H Fang, Israel Franco, Joseph M Pizzuti, et al.
BMJ Open|November 5, 2024
Identifying priorities for future research on reducing and stopping psychiatric medication: results of a James Lind Alliance priority-setting partnershipMiriam Boland, Agnes Higgins, Claire Beecher, et al.
BMJ Open|June 9, 2025
Protocol for the development of a transdiagnostic core outcome set for mental health disorders in adults: the Patient Important Outcomes in Psychiatry (PIO-Psych) InitiativeSophie Juul, Pascal Faltermeier, Johanne Juul Petersen, et al.
Pageof 9